Database

You are now searching through our whole database. To make more specific queries, you can use our menu or go directly to papers, companies, trials, or events.

This topic page is linked to our papers but doesn’t yet have a full explanation.
Published: 2022-09-29
This topic page is linked to our papers but doesn’t yet have a full explanation.
Published: 2022-09-29
This topic page is linked to our papers but doesn’t yet have a full explanation.
Published: 2022-09-29
This topic page is linked to our papers but doesn’t yet have a full explanation.
Published: 2022-09-29
This topic page is linked to our papers but doesn’t yet have a full explanation.
Published: 2022-09-29
This topic page is linked to our papers but doesn’t yet have a full explanation.
Published: 2022-09-29
This topic page is linked to our papers but doesn’t yet have a full explanation.
Published: 2022-09-29
This open-label trial (n=20) will take EEG measures on participants who receive two doses of psilocybin (up to 25mg). Next to the brain measures, participants will be studied up to six months later.
Category: Trials
Published: 2022-09-29
This open-label trial (n=24) investigates the difference between those who are and aren't taking antidepressants (SSRIs) who will receive SPL026 (DMT fumarate). As a Phase I study, the main concern is safety and tolerability. With 24 participants, some signal on effectiveness might be detected.
Category: Trials
Published: 2022-09-29
This RCT (n=24) does a direct comparison, the first one in a double-blind trial, of MDMA, psilocybin, and 2C-B (a novel psychedelic with MDMA & psilocybin-like effects). Next to a placebo, the dosages of MDMA (125mg) and psilocybin (25mg) are high, whilst that of 2C-B will be a variety of doses (10, 20, 30mg). All participants will receive all compounds and a placebo (cross-over study design).
Category: Trials
Published: 2022-09-29

Psychedelic Database

Find everything on psychedelics as medicine. This page allows you to search through our whole database, from research papers to news articles, and from clinical trials to academic articles.

Next to our databases, don’t forget to check out our reports. The reports bring together the separate pieces of information from our database entries into written reports.

Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account